Goldman Sachs’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,305
| Closed | -$14K | – | 4391 |
|
|
2019
Q3 | $14K | Sell |
1,305
-65,958
| -98% | -$708K | ﹤0.01% | 4200 |
|
|
2019
Q2 | $1.14M | Buy |
67,263
+51,885
| +337% | +$882K | ﹤0.01% | 3110 |
|
|
2019
Q1 | $518K | Sell |
15,378
-5,188
| -25% | -$175K | ﹤0.01% | 3552 |
|
|
2018
Q4 | $600K | Sell |
20,566
-2,327
| -10% | -$67.9K | ﹤0.01% | 3341 |
|
|
2018
Q3 | $1.41M | Sell |
22,893
-3,333
| -13% | -$205K | ﹤0.01% | 3028 |
|
|
2018
Q2 | $1.94M | Buy |
26,226
+9,378
| +56% | +$692K | ﹤0.01% | 2898 |
|
|
2018
Q1 | $1.11M | Buy |
16,848
+1,962
| +13% | +$129K | ﹤0.01% | 3149 |
|
|
2017
Q4 | $1.25M | Buy |
14,886
+1,926
| +15% | +$162K | ﹤0.01% | 3056 |
|
|
2017
Q3 | $1.5M | Sell |
12,960
-840
| -6% | -$97K | ﹤0.01% | 3024 |
|
|
2017
Q2 | $1.61M | Buy |
13,800
+9,534
| +223% | +$1.11M | ﹤0.01% | 2908 |
|
|
2017
Q1 | $526K | Buy |
4,266
+1,386
| +48% | +$171K | ﹤0.01% | 3491 |
|
|
2016
Q4 | $392K | Buy |
2,880
+1,638
| +132% | +$223K | ﹤0.01% | 3587 |
|
|
2016
Q3 | $247K | Sell |
1,242
-4,864
| -80% | -$967K | ﹤0.01% | 3802 |
|
|
2016
Q2 | $791K | Buy |
+6,106
| New | +$791K | ﹤0.01% | 3074 |
|
|
2016
Q1 | – | Sell |
-7,722
| Closed | -$1.57M | – | 4652 |
|
|
2015
Q4 | $1.57M | Buy |
+7,722
| New | +$1.57M | ﹤0.01% | 2643 |
|
|
2015
Q2 | – | Sell |
-1,456
| Closed | -$337K | – | 4776 |
|
|
2015
Q1 | $337K | Sell |
1,456
-2,219
| -60% | -$514K | ﹤0.01% | 3562 |
|
|
2014
Q4 | $847K | Buy |
+3,675
| New | +$847K | ﹤0.01% | 3045 |
|